Possibility of generating lung tissue for transplant using a patient’s own cells
For the first time, scientists have succeeded in transforming human stem cells into functional lung and airway cells. The advance, reported by Columbia University Medical Center (CUMC) researchers, has significant potential for modeling lung disease, screening drugs, studying human lung development, and, ultimately, generating lung tissue for transplantation. The study was published today in the journal Nature Biotechnology.
“Researchers have had relative success in turning human stem cells into heart cells, pancreatic beta cells, intestinal cells, liver cells, and nerve cells, raising all sorts of possibilities for regenerative medicine,” said study leader Hans-Willem Snoeck, MD, PhD, professor of medicine (in microbiology & immunology) and affiliated with the Columbia Center for Translational Immunology and the Columbia Stem Cell Initiative. “Now, we are finally able to make lung and airway cells. This is important because lung transplants have a particularly poor prognosis. Although any clinical application is still many years away, we can begin thinking about making autologous lung transplants—that is, transplants that use a patient’s own skin cells to generate functional lung tissue.”
The research builds on Dr. Snoeck’s 2011 discovery of a set of chemical factors that can turn human embryonic stem (ES) cells or human induced pluripotent stem (iPS) cells into anterior foregut endoderm—precursors of lung and airway cells. (Human iPS cells closely resemble human ES cells but are generated from skin cells, by coaxing them into taking a developmental step backwards. Human iPS cells can then be stimulated to differentiate into specialized cells—offering researchers an alternative to human ES cells.)
In the current study, Dr. Snoeck and his colleagues found new factors that can complete the transformation of human ES or iPS cells into functionawebl lung epithelial cells (cells that cover the lung surface). The resultant cells were found to express markers of at least six types of lung and airway epithelial cells, particularly markers of type 2 alveolar epithelial cells. Type 2 cells are important because they produce surfactant, a substance critical to maintain the lung alveoli, where gas exchange takes place; they also participate in repair of the lung after injury and damage.
The findings have implications for the study of a number of lung diseases, including idiopathic pulmonary fibrosis (IPF), in which type 2 alveolar epithelial cells are thought to play a central role. “No one knows what causes the disease, and there’s no way to treat it,” says Dr. Snoeck. “Using this technology, researchers will finally be able to create laboratory models of IPF, study the disease at the molecular level, and screen drugs for possible treatments or cures.”
“In the longer term, we hope to use this technology to make an autologous lung graft,” Dr. Snoeck said. “This would entail taking a lung from a donor; removing all the lung cells, leaving only the lung scaffold; and seeding the scaffold with new lung cells derived from the patient. In this way, rejection problems could be avoided.” Dr. Snoeck is investigating this approach in collaboration with researchers in the Columbia University Department of Biomedical Engineering.
The Latest on: Human stem cells
- 'Synthetic embryo' breakthrough but growing human organs far offon August 5, 2022 at 4:10 am
PARIS: Stem cell scientists say they have created "synthetic embryos" without using sperm, eggs or fertilisation for the first time, but the prospect of using such a technique to grow human organs for ...
- Scientists achieve 'synthetic embryo' breakthrough but growing human organs still far offon August 5, 2022 at 3:55 am
Stem cell scientists say they have created "synthetic embryos" without using sperm, eggs or fertilisation for the first time, but the prospect of using such a technique to grow human organs for ...
- Scientists Develop The First "Synthetic Embyros" Using Mice Stem Cellson August 5, 2022 at 1:41 am
Without using sperm, eggs, or a womb, researchers created "synthetic embryos" from mice cells.The technology might be used as a foundation for the development of new organs.
- Hyaluranic acid wakes up stem cells to start muscle repairon August 4, 2022 at 7:59 pm
A new study published in the journal Science reveals a unique form of cell communication that controls muscle repair.
- Researchers discover two signaling pathways that are downregulated in human hearts after birthon August 4, 2022 at 7:27 pm
Published today in Stem Cell Reports, researchers from the University of Minnesota Medical School discovered two signaling pathways that are downregulated in human hearts after birth.
- In world first, artificial mouse 'embryos' were grown without the need for a womb, sperm, or eggon August 4, 2022 at 5:19 am
The "embryos" grew placentas and organs and could be used for research. We're still a long way before we can make humans embryos that way.
- Synthetic mouse embryos created from stem cells — without sperm, eggs, or a uteruson August 3, 2022 at 6:15 am
The advance opens new avenues for studying how stem cells form organs and better understanding how certain mutations drive developmental diseases.
- New Stem Cell Research Could Cure Baldness, Scientists Sayon July 29, 2022 at 11:55 am
The study has discovered that a protein known as TGF-beta can turn on or off hair stem cells, making them grow or die.
- Progress toward a stem cell–based therapy for blindnesson July 29, 2022 at 6:34 am
What if, in people with blinding retinal disorders, one could simply introduce into the retina healthy photoreceptor cells derived in a dish from stem cells, and restore sight?
via Bing News
The Latest on: Autologous lung graft
- Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlightson August 4, 2022 at 10:03 pm
Celyad Oncology SA (Euronext & Nasdaq: CYAD) (the “Company”), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for ...
- Digital life coaching during stem cell transplantationon July 29, 2022 at 9:40 am
Enrolled patients received 16 weeks of virtual access to a life coach beginning on day −5 before stem cell transplantation ... dose chemotherapy followed by autologous SCT can engage ...
- Favorable Consolidative Effect of High-Dose Melphalan and Total-Body Irradiationon July 28, 2022 at 5:00 pm
and lung function. Patients were excluded if they had previously received stem cell transplantation; had other active malignancies; had severe comorbidities interfering with the completion of ...
- Bone marrow transplantationon July 28, 2022 at 1:40 pm
High incidence of secondary failure of platelet recovery after autologous and syngeneic peripheral blood stem cell transplantation in acute promyelocytic leukemia. Human platelet lysate allows ...
- Stem cell transplantation for AL amyloidosis leads to long-term survival and possible cure in selected patientson July 19, 2022 at 10:33 am
For some and highly selected patients, treatment includes high-dose chemotherapy (melphalan) and autologous (one's own) stem cell transplantation (HDM/SCT). In the largest study of its kind ...
- Stem cell transplantation for AL amyloidosis leads to long-term survival and possible cure in selected patientson July 14, 2022 at 10:26 am
Citation: Stem cell transplantation for AL amyloidosis leads to long-term survival and possible cure in selected patients (2022, July 14) retrieved 2 August 2022 from https://medicalxpress.com ...
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Diseaseon July 13, 2022 at 5:00 pm
The increased numbers of Treg cells expressed the transcription factor forkhead box P3 (FOXP3) and could inhibit autologous Tcon ... hematopoietic stem-cell transplantation (HSCT) invokes donor ...
- Intracoronary Injection of Mononuclear Bone Marrow Cells in Acute Myocardial Infarctionon July 13, 2022 at 5:00 pm
Lung cancer was diagnosed in one patient ... Committee and the Data and Safety Monitoring Board of the Autologous Stem-Cell Transplantation in Acute Myocardial Infarction (ASTAMI) study are ...
- Dental Bone Graft Market Registered at CAGR 11.9% New Business Opportunities, Growth Rate, Development Trend and Feasibility Studies by 2029on July 7, 2022 at 5:05 am
The MarketWatch News Department was not involved in the creation of this content. Jul 07, 2022 (Heraldkeepers) -- Dental Bone Graft Market research report has been generated by considering a range ...
- Outcomes of Refractory and Relapsed Hodgkin Lymphoma With Autologous Stem-Cell Transplantation: A Single Institution Experienceon November 22, 2019 at 4:00 am
Conventional salvage therapies and autologous stem-cell transplantation is usually considered the standard ... Pulmonology evaluation for lung toxicities was performed at 2 years after treatment and ...
via Bing News